Adoptive cord blood immunotherapy

Cord blood-derived virus-specific T cells

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Adoptive cord blood immunotherapy, covering 2024-08-28 to 2024-08-28. Get the full timeline:

Most recent: Clinical Trial Update: Adoptive Cord Blood Immunotherapy for EBV, CMV, BKV and Adenovirus Reactivation/Infection or Prophylaxis [Phase 1, Phase 2]

See pricing